Source:http://linkedlifedata.com/resource/pubmed/id/21067862
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-11-30
|
pubmed:abstractText |
MiR-34a was identified as one of the down-regulated micro-RNAs (miRs) in human colorectal cancer 5-fluorouracil (5-FU)-resistant DLD-1 cells compared with those in the parental DLD-1 cells. Exposure to 5-FU at 30 ?M activated phosphoinositide 3-kinase (PI3K)/Akt signaling markedly from 12h up to 48 h in the 5-FU-resistant cells compared with that in the parental cells and resulted in an overt difference in growth at those times. Furthermore, the expression of miR-34a in the 5-FU-resistant cells was sustained at a low-level, whereas it was up-regulated in the parental cells after the 5-FU treatment. Sirt1, which is one of the target genes for miR-34a and related to drug-resistance, was strikingly up-regulated in the 5-FU-resistant cells. The ectopic expression of miR-34a in the 5-FU-resistant cells inhibited growth, as in the parental cells, and attenuated the resistance to 5-FU through the down-regulation of Sirt1 and E2F3. Moreover, the silencing of Sirt1 significantly canceled the resistance to 5-FU in the 5-FU-resistant cells. These findings suggest that miR-34a targeting the Sirt1 and E2F3 genes could negatively regulate, at least in part, the resistance to 5-FU in human colorectal cancer DLD-1 cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/E2F3 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/E2F3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/MIRN34 microRNA, human,
http://linkedlifedata.com/resource/pubmed/chemical/MicroRNAs,
http://linkedlifedata.com/resource/pubmed/chemical/SIRT1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Sirtuin 1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1872-7980
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
300
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
197-204
|
pubmed:meshHeading |
pubmed-meshheading:21067862-Antineoplastic Agents,
pubmed-meshheading:21067862-Blotting, Western,
pubmed-meshheading:21067862-Cell Line, Tumor,
pubmed-meshheading:21067862-Drug Resistance, Neoplasm,
pubmed-meshheading:21067862-E2F3 Transcription Factor,
pubmed-meshheading:21067862-Fluorouracil,
pubmed-meshheading:21067862-Gene Expression,
pubmed-meshheading:21067862-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:21067862-Humans,
pubmed-meshheading:21067862-In Situ Hybridization,
pubmed-meshheading:21067862-MicroRNAs,
pubmed-meshheading:21067862-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:21067862-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:21067862-Signal Transduction,
pubmed-meshheading:21067862-Sirtuin 1,
pubmed-meshheading:21067862-Transfection
|
pubmed:year |
2011
|
pubmed:articleTitle |
Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells.
|
pubmed:affiliation |
Gifu University, Yanagido, Japan. yakao@gifu-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|